TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
TCL Archive House Committee Probes NCI $5.2 Billion Sole-Source Contract With SAIC-Frederick. November 14, 2008
TCL Archive “Clinical research of all kinds in the IRP lacks a rigorous, centralized process for peer review.” July 21, 1995
TCL Archive Zubrod To Retire as Miami Director; Baker Succeeds Brennan As Director Of Detroit Center January 29, 1988